Curanex Pharmaceuticals
CURX
11 hedge funds and large institutions have $89K invested in Curanex Pharmaceuticals in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
38% more funds holding
Funds holding: 8 → 11 (+3)
0.02% more ownership
Funds ownership: 1.16% → 1.18% (+0.02%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
47% less capital invested
Capital invested by funds: $168K → $89K (-$78.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$18.9K |
| 2 |
VF
Virtu Financial
New York
|
+$18.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$16.3K |
| 4 |
Jane Street
New York
|
+$11.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$29K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$26.5K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$26.2K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$5.39K |
| 5 |
Citigroup
New York
|
-$3.78K |
CURX Hedge Fund Activity: Q2 2026 in Review
11 of the 8,336 institutional investors tracked by Wall St. Rank reported a position in Curanex Pharmaceuticals (CURX) for Q2 2026, worth a combined $89K — down 47% from $168K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CURX positions and 3 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $18.9K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $29K sold.
- 11 institutional investors held Curanex Pharmaceuticals (CURX) as of Q2 2026, up from 8 in Q1 2026.
- Funds reported $89K of Curanex Pharmaceuticals stock for Q2 2026, down 47% quarter-over-quarter.
- 6 funds opened new Curanex Pharmaceuticals positions in Q2 2026 and 3 closed out, a net change of +3 holders.
- The largest Curanex Pharmaceuticals buyer in Q2 2026 was Renaissance Technologies, an estimated $18.9K added.
- The largest Curanex Pharmaceuticals seller in Q2 2026 was Two Sigma Securities, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2026.